{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:52:16Z","timestamp":1781661136981,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2023R1A2C1002539"],"award-info":[{"award-number":["NRF-2023R1A2C1002539"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2022R1C1C1007681"],"award-info":[{"award-number":["NRF-2022R1C1C1007681"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00523325"],"award-info":[{"award-number":["RS-2025-00523325"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152711","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:22:45Z","timestamp":1758900165000},"page":"152711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immune-modulatory effects of low-dose radiotherapy through macrophage polarization and transcriptional rewiring in triple-negative breast cancer"],"prefix":"10.1016","volume":"786","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanny","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6156-0744","authenticated-orcid":false,"given":"Byoung Hyuck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152711_bib1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced Non\u2012Small-Cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152711_bib2","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(17)31601-X","article-title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","volume":"390","author":"Schachter","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2025.152711_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00262-021-03018-y","article-title":"Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1\/PD-L1 inhibitors","volume":"71","author":"Kang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2025.152711_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511887","article-title":"Biomarkers for immune checkpoint inhibitor response in NSCLC: current developments and applicability","volume":"24","author":"Tostes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152711_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152711_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152711_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non-small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbrc.2025.152711_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/ijms20092173","article-title":"Stereotactic ablative radiotherapy combined with immune checkpoint inhibitors reboots the immune response assisted by immunotherapy in metastatic lung cancer: a systematic review","volume":"20","author":"Chicas-Sett","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152711_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/0284186X.2023.2228991","article-title":"Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study","volume":"62","author":"Zhang","year":"2023","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbrc.2025.152711_bib10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","article-title":"Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites","volume":"30","author":"Hou","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152711_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","article-title":"Radiation-induced amphiregulin drives tumour metastasis","volume":"643","author":"Piffk\u00f3","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152711_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/bjr\/tqae100","article-title":"Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy","volume":"97","author":"Passelli","year":"2024","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bbrc.2025.152711_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.152711_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2025.152711_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s40425-019-0718-6","article-title":"Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy","volume":"7","author":"Menon","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2025.152711_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2020.05.002","article-title":"Effect of low-dose radiation therapy on abscopal responses to hypofractionated radiation therapy and Anti-PD1 in mice and patients with non-small cell lung cancer","volume":"108","author":"Yin","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrc.2025.152711_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.152711_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2025.152711_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2021.06.037","article-title":"High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial","volume":"162","author":"Patel","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbrc.2025.152711_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70030","article-title":"Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities","volume":"14","author":"Hartley","year":"2025","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.bbrc.2025.152711_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41577-021-00568-1","article-title":"Immunomodulation by radiotherapy in tumour control and normal tissue toxicity","volume":"22","author":"Cytlak","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2025.152711_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3857\/roj.2023.00185","article-title":"Radiotherapy combined with immunotherapy could improve the immune infiltration of melanoma in mice and enhance the abscopal effect","volume":"41","author":"Zheng","year":"2023","journal-title":"Radiat. Oncol. J"},{"key":"10.1016\/j.bbrc.2025.152711_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3857\/roj.2022.00521","article-title":"Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers","volume":"41","author":"Novikov","year":"2023","journal-title":"Radiat. Oncol. J"},{"key":"10.1016\/j.bbrc.2025.152711_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3161750","article-title":"Low-dose irradiation differentially impacts macrophage phenotype in dependence of fibroblast-like synoviocytes and radiation dose","volume":"2019","author":"Deloch","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbrc.2025.152711_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.152711_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","article-title":"High-Dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152711_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1186\/s12885-021-08536-7","article-title":"SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.152711_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12957-023-03122-6","article-title":"Dissociated response to PD-1 inhibitors combined with radiotherapy in patients with advanced metastatic solid tumors: a single-center experience","volume":"21","author":"Yu","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbrc.2025.152711_bib29","article-title":"Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors","volume":"13","author":"Ji","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25014275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25014275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:59:36Z","timestamp":1777406376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25014275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"alternative-id":["S0006291X25014275"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152711","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-modulatory effects of low-dose radiotherapy through macrophage polarization and transcriptional rewiring in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152711"}}